
MYND Life Sciences Inc. Announces Collaborative Research Agreement with the University of British Co
VANCOUVER, BC, Feb. 2, 2021 /PRNewswire/ – MYND Life Sciences Inc. (“MYND“) a life sciences company focused on novel psychedelic drug...
MYND Life Sciences Inc. Announces Collaborative Research Agreement with the University of British Co
MYND Life Sciences CEO Invited to Present at Canaccord Genuity’s New Paradigms and Treatment A
MYND Life Sciences Inc. Closes $2.4 Million Private Placement and Provides Update on Planned Listing